You Remember This One?


Nice $7,027 start to the week on my end applying high probability trade ideas…

Today, financial professionals at Morgan Stanley are analyzing a stock which I just made 196% on last week as it was my #1 trade idea on May 6, 2020.

Today, I’m interested in moving the other direction on it, and I suspect some at Morgan Stanley are as well!

Ticker Code Ticker Name Ticker Industry Price Change Average Volume (50)*
ACB Aurora Cannabis Inc Drug Manufacturers – Specialty & Generic 30.37% 15,019,194
KTOV KITOV PHARMA LT/S ADR Biotechnology 44.64% 21,231,681
SPOT Spotify Technology SA Internet Content & Information 36.42% 1,744,952
INO Inovio Pharmaceuticals Inc Biotechnology 48.55% 40,677,485
NVAX Novavax, Inc. Biotechnology 71.81% 11,100,926
WBA Walgreens Boots Alliance Inc Pharmaceutical Retailers -8.52% 6,707,004
SNDX Syndax Pharmaceuticals Inc Biotechnology 30.08% 1,401,338
CHK Chesapeake Energy Corporation Oil & Gas E&P -149.21% 3,014,128
BABA Alibaba Group Holding Ltd – ADR Internet Retail 3.59% 20,648,485
DSS Document Security Systems, Inc. Specialty Business Services 23.75% 275,195
PENN Penn National Gaming, Inc Resorts & Casinos 56.81% 14,208,069
IQ IQIYI Inc Internet Content & Information -12.16% 7,832,697
MRNA Moderna Inc Biotechnology 48.10% 24,051,944
GE General Electric Company Specialty Industrial Machinery -16.76% 126,460,843
TRIL Trillium Therapeutics Inc Biotechnology 35.97% 2,306,206
CRWD Crowdstrike Holdings Inc Software – Application 29.83% 4,205,427
BYND Beyond Meat Inc Packaged Foods 49.88% 11,274,089
HGSH CAHS China HGS Real Estate, Inc. Common Stock Real Estate – Development 20.00% 131,820
LK Luckin Coffee Inc – ADR Restaurants -1176.53% 10,989,912
MRVL Marvell Technology Group Ltd. Semiconductors 25.56% 8,884,418

America’s #1 Premarket and Day Trader

Only minutes after Benchmark upgraded their rating on Inovio Pharmaceuticals (NYSE: INO), a shareholder rights law firm announced the initiation of an investigation of the officers and directors of the company.

Something might have seemed a little fishy!

It is rumored that INO may have recently breached fiduciary duties and violated Securities and Exchange Commission Acts.

On top of that, in recent days INO has been accused of falsifying their favorable COVID-19 vaccine claims made last week.

And as mentioned last week, I was interested in a short-term upside move on their COVID-19 vaccine catalyst, but also stated that I didn’t like the company’s management and may look to short it back down later.

I think that time has now come as I am bearish on INO in the long-term and retain my cynicism of the company’s officers and directors (who are now under investigation).

A mistake many new traders make when attempting to short stocks down after they make significant moves up is either chasing them or not having a trade plan.

I’ve been planning this possible short opportunity for about a week, and today I believe it could come together, allowing me to initiate a starter position.

$15/share has been tough resistance for INO to trade above for more than an hour or two at a time so far in 2020. Therefore, should INO trade around $15/share, that’s exactly when I’ll initiate a bearish position.

If this setup comes together today, I suspect I won’t be the only one placing a bearish bet on INO itself, and you bet I’ll be watching Wall Street’s biggest players trading activity on INO today as well!

Let me know how you do today!

Yours for TrackStar trading,

Davis Martin
America’s #1 Premarket and Day Trader

Disclaimer: This is not investment advice. This article is for information purposes only and opinion-based on financial advisor data across a selection of websites. Investors should be cautious about any and all investments and are advised to conduct their own due diligence prior to making any investment decisions.